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Abstract
Objectives: Oral Lichen Planus (OLP) is a chronic disease of the oral mucosa, and according to the WHO also 
a pre malignant condition. Micro-RNAs are short non coding RNAs capable of regulating mRNA expression. 
MiRNA:scan be detected in tissue, blood and human whole saliva (HWS) and recently we have shown miR-203 
to be up-regulated in tissue from OLP lesions.
Study Design: In order to see whether mRNA as well as miR-203 could be detected also in HWS, saliva from 
healthy controls and patients with OLP were analysed using two different PCR methods.
Results: Results showed low mRNA and miRNA levels in general in HWS samples, making it hard to generate 
conclusive results. 
Conclusions: In order to make HWS a valuable source for different analyses, more sensitive PCR techniques ca-
pable of detecting very low levels of mRNAand miRNAas well as more efficient methods for extraction of RNA 
are needed. 
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Introduction
Oral Lichen Planus (OLP) is a chronic disease affect-
ing the oral mucosa, and often also other areas such 
as the genital mucosa. The prevalence varies between 
0.5-2.2% in the normal population, and the disease is 
most common in middle-aged women. The specific eti-
ology behind OLP is unknown even if the disease shows 
some typical features of autoimmunity (1,2). Clinically 
the most common forms are reticular and erosive, and 
symptoms range from none to almost unbearable pain 
(3). OLP is by the World Health Organization, WHO, 
classified as a potentially malignant condition with 
higher risk of developing into squamous cell carcino-
ma, SCC. The potential for malignant development has, 
however, been widely questioned (4).
Human whole saliva, HWS, consists mainly of water 
and a broad spectrum of proteins, nucleic acids, electro-
lytes and hormones. Its composition and regulation is 
complex, depending on constantly varying exogenous 
and endogenous factors such as overall health of the 
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individual, drugs, hormonal status, age, heredity and 
oral hygiene (5). HWS is mainly secreted from the ma-
jor glands, the parotid, sublingual and submandibular, 
and only around 10% comes from the accessory glands. 
Salivary secretion can be both basal and stimulated, the 
latter generating a volume of 500-1000 ml per day (6). 
No significant difference in either composition or vol-
ume has been seen between genders, whereas a reduced 
basal secretion volume has been shown with age (7). 
As HWS can be easily collected through a non invasive 
technique (7) its potential use in different analyses has 
been under investigation in several studies. 
MicroRNAs (miRNAs) are short, 22nt long, non-coding 
RNAs present in tissue, blood and HWS. They regulate 
messenger-RNAs (mRNAs) resulting in repression or 
inhibition of proteins (8). A single miRNA can target 
multiple mRNAs enabling it to simultaneously affect 
several pathways, and many miRNAs have shown to be 
important in carcinogenesis and the tumorigenic pro-
cess (9). A study of patients with oral carcinoma showed 
significantly higher expression of microRNA-31, miR-
31, in saliva from tumour patients compared to a control 
group (9). Looking at tissue samples, we have shown 
another micro-RNA, miR-203, which is expressed only 
in keratinocytes (10,11), to be over expressed in OLP le-
sions compared to healthy controls (12). Based on these 
results, we now wanted to investigate if this over ex-
pression also could be seenin HWS from patients with 
OLP compared to healthy controls.  
Material and Methods
-Patient material and collecting process
The study was approved by the Ethical Committee at 
Umeå University, Dnr 2011-252-32M, and all partici-
pants had been given information both orally and in 
writing. The inclusion criteria for the controls were: 
age 18 or above, no drugs affecting salivary secretion 
and no systemic disease. Saliva was also collected from 
consecutive patients referred to the specialist clinic at 
the Department of Odontology, Umeå University, clini-
cally and histologically diagnosed with OLP. Samples 
were collected using a stimulated saliva test (6), and 
participants unable to provide 2ml of saliva during the 
given five-minute time period were excluded. Samples 
from a total of 21 individuals were collected, 14 healthy 
individuals and 7 diagnosed with OLP. The HWS sam-
ples were divided into three 200µl aliquots, each direct-
ly mixed with 1ml of Saliva degradation inhibitor (Sali-
va Incubation Mix, Qiagen Germany) and kept at room 
temperature for 1h before freezing and storage at -80°C, 
shown to be most efficient in prevention of degradation 
(7). From each participant there were thus three samples 
available for further analysis. The collection and han-
dling process is summarized in figure 1, Part 1.
In order to determine if addition of saliva inhibitor 
could interfere with the PCR reactions 5 of the samples 
from Part 1 were compared with 5 new HWS samples 
from healthy individuals without addition of any saliva 
inhibitor. As a control for the PCR reaction 5 cDNA 
samples from tissue previously analyzed for expression 
of miR-203 (12) were included (Fig. 1, Part 2).
-PCR Analyses
To start with, we wanted to see if RNA was detectable at 
all in our HWS-samples, and thus the QX100™ Droplet 
Digital™ PCR (ddPCR™) system, was chosen due to its 
capability to detect very low levels of RNA (>66ng/20µL/
sample). Primers for corneodesmosin (CDSN) which 
previously has been shown to be highly up regulated in 
LP-lesions (13) and β-Actin as reference were chosen for 
analysis (14). In the first run FaDu cells (hypopharyngeal 
Fig. 1. General workflow displaying outline for collection and handling of samples 
and analyses performed. 
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Individual ng/µl 260/280 ng/µl 260/280
Sample A B
1 -0,25 9,64 21,15 1,63
2 -4,63 1,3 31,4 1,54
3 -1,51 0,79 18,59 1,57
4 7,08 2,54 22,9 1,48
5 15,43 1,78 18,45 1,5
6 10,42 1,42 21,86 1,59
7 5,58 2,13 20,17 1,62
8 2,65 17 40,98 1,53
9 160,87 1,51 20,82 1,41
10 -3,16 1,08 19,78 1,41
11 -27,1 1,44 20,12 1,52
12 0,37 1,66 34,82 1,56
13 -1,1 2,04 26,38 1,59
14 0,78 0,82 22,45 1,45
21 1,92 1,83 -0,64 0,74
22 -2,94 1,35 -2,87 1,55
23 80,97 1,55 2,57 4,26
24 6,47 1,99 0,34 -0,4
25 -0,74 0,41 1,49 -29
26 -2,01 2,82 1,3 -6,2
27 -0,64 0,57 2,5 2,29
Table 1. Quality control. Only two samples (5 and 24) fulfilled the 
quality control based on the NanoDrop100 Technical Bulletin with 
an RNA content of > 3ng/μL and a 260/280 value of 1.80-2.00.
carcinoma; ATCC) and HEKa cells (Human epidermal 
kerationcytes, Life Technologies, USA) were used as po-
sitive controls.
In the second part the miRCURYLNA™ Universal RT 
microRNA PCR kit (Exiqon, Denmark) was used for 
detection of miRNA, consisting of first strand cDNA 
synthesis and real time PCR amplification. Quantitative 
RT-PCR for miRNAs was performed with IQ5 multi-
color real-time PCR detection system (Bio-Rad labora-
tories Inc., USA) 
Samples from all three groups in Part 2 were analyzed 
simultaneously using primers for miRNA-203 and 
RNU48, also called 48u, as a reference gene (15). All 
samples were tested in duplicate and a requirement for 
detection in both subsamples was set as inclusion crite-
ria in order to be considered positive.
-RNA extraction and cDNApreparation
The RNeasy Micro Kit (Qiagen, Hilden, Germany) was 
used for extraction of RNA. Samples were thereafter 
analyzed for RNA levels and quality using the Nano-
Drop-system (NanoDrop ND-1000 Spectrophotometer, 
NanoDrop v 3.1.2 software). The quality control crite-
ria, based upon the NanoDrop 100 Technical & Bulletin, 
with an RNA content of >3ng/μL and a 260/280value of 
1.80-2.00 wasapplied.
As two different PCR methods were used, cDNA syn-
thesis was accordingly performed in two different 
ways. For samples in Part 1, using the QX100 Droplet 
Digital PCR ddPCR™ (BioRad, California, USA) the 
cDNA-kit “Droplet PCR Supermix” (BioRad, Cali-
fornia, USA) was used, and for samples in Part 2 ana-
lyzed by Bio-Rad iQ5 Real Time PCR Detection Sys-
tem (BioRad, California, USA) the cDNA kit included 
in ExiqonmiRCURY LNA Universal RT microRNA 
PCR - kit (Exiqion, Copenhagen, Denmark) was used. 
Samples were kept on ice during the whole process and 
all samples were analyzed in duplicate during the PCR 
process. For samples in Part 2, RNA-extraction, Nano-
Drop measurement and cDNA synthesis was performed 
simultaneously for the HWS samples, whereas cDNA 
already was available from tissue samples (12).
-Statistical Analysis
All data were converted to Microsoft Excel for further 
analysis and graph formation, except data collected from 
Part 1, and analyzedusing the “QuantaSoft v 1.4.0”. 
Results
-RNA extraction and quality
RNA was extracted at two separate occasions, A and 
B, from each of the 21 HWS samples in Part 1, giving a 
total of 42 RNA extracts. However, as shown in table 1 
only 2 out of the 42 samples met the quality control cri-
teria (5A and 24A). Twelve of the 42 samples had a neg-
ative ng/µL-value and three a negative 260/280-value.
-Droplet Digital™ PCR (ddPCR™)
Corneodesmosin, CDSN, could only be detected in 
HEKa cells, whereas β-actin was detected in one HWS 
sample, 5A, but not in its duplicate 5B. Looking at qual-
ity control, the 5A sample met the quality control crite-
ria for the NanoDrop whereas 5B did not.
-Bio-Rad iQ5 (RT/PCR)
As shown in figure 2 both miR-203 and the reference 
gene 48u could be detectedin 4 out of the 15 analyzed-
samples. Three of these were tissue samples, previously 
analyzed (12), and now included as controlsfor the PCR 
reaction, and one was aHWS sample from Part 2, col-
lected without addition of saliva inhibitor. MiR-203 was 
detected in duplicate in 6 out of 15 samples, and the 
reference gene 48u in 9 out of 15 samples. 
Discussion
The possibility to use HWS in different analyses is very 
attractive, mainly due to the non invasive way of col-
lecting samples. A problem can, however, be levels of-
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Fig. 2. Results from Part 2 displaying results (CƬ-Mean) from the RT/PCR analysis of miR-203 and the refe-
rence gene 48u.  
RNA, which in our HWS samples werelow compared 
to previous studies reporting 5-10 times higher values 
(7,16). These studies did not either report samples with 
negative values, whereas almost a third, 29%, of our 
samples showed negative values, in our experience rep-
resenting values too low to be measured. Comparing 
protocols between the studies showed that Patel et al. 
(7) used a different kit for collection of saliva and ex-
traction of RNA while Pandit and coworkers (16) had 
used a modified extraction method with the addition 
of isopropanol alcohol/chloroform without addition of 
a saliva inhibitor. The addition of isopropanol alcohol 
and chloroform in the extraction process aids in remov-
ing proteins, and at least theoretically, the extracts used 
in theirstudy couldthus be more “pure RNA extracts” 
compared to ours. Furthermore, their samples were 
constantly kept at +4°C, whereas we in our experiment 
followed the protocol from the manufacturer and kept 
samples at room temperature after the addition of sa-
liva inhibitor. Temperature changes may inflict on RNA 
degradation in HWS during the extraction process. The 
sensitivity of NanoDrop measurements must also be ad-
dressed based on the inconsistency seen when repeat-
ing measurement of the same sample. Using NanoDrop 
only 1µL of the sample is needed, and increasing the 
volume to 2µL did not give more consistent results. We 
chose to include a standard amount of 10µL from each 
samplein the cDNA synthesis process, irrespective of 
the measured values. 
The fact that our samples originated from people of dif-
ferent ethnic origin is less likely to explain the differ-
ence in results, as is gender (14).
The Digital Droplet, dd, PCR technique is based on cre-
ation and classification on droplets without any ampli-
fication. When analyzing our results, it must be noticed 
that all control samples from cell lines showed positive 
results, supporting that the method was working prop-
erly. In the HWS samples levels of β-actin and CDSN 
were, however, most likely too low to be detected, even 
when using the sensitive ddPCR method. 
Strangely enough, the RT/PCR method which is less 
sensitive in detection of low levels of RNAgavemore 
positive results. Of the 15 samples analyzed in Part 2, 
both miR-203 and 48u could be detected in duplicate in 
three tissue samples previously analyzed (12) and one 
HWS sample where no saliva inhibitor had been added. 
In another HWS sample without inhibitor the reference 
gene 48u was detected, and in two of the 5 HWS sam-
ples with inhibitor miR-203 could be detected. Based 
on this limited material it is, however, not possible to 
judge whether addition of saliva inhibitor has any im-
pact on the possibility to detect RNA and miRNA in 
HWS samples.
In summary, we were in our material not able to detect 
RNA and miRNA in most of our HWS samples by the 
use of two different PCR-methods. This was most likely 
due to extremely low levels of RNA present in HWS 
compared to tissue samples. In order to successfully 
use HWS in future analyses there is therefore a need for 
more efficient methods for RNA extraction and more 
sensitive techniques for analyses. Alternatively pre-
amplification could be considered in analysis of these 
samples (17).
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